Codexis, Inc. 0I0X.L
0I0X.L
Codexis, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0H8I.L
Accuray Incorporated 0H8T.L
Aclaris Therapeutics, Inc. 0SZI.L
Corbus Pharmaceuticals Holdings, Inc. 0H7R.L
Abeona Therapeutics Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0IFK.L
Editas Medicine, Inc.
Codexis, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0J4V.L
Heron Therapeutics, Inc. 0H8I.L
Accuray Incorporated 0H8T.L
Aclaris Therapeutics, Inc. 0SZI.L
Corbus Pharmaceuticals Holdings, Inc. 0H7R.L
Abeona Therapeutics Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0IFK.L
Editas Medicine, Inc.
Performance
| Periode | 0I0X.L | 0R1D.L | 0J4V.L | 0H8I.L | 0H8T.L | 0SZI.L | 0H7R.L | 0KCC.L | 0HIY.L | 0IFK.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 14.87 % | -14.52 % | -47.35 % | -1.29 % | 72.65 % | 135.33 % | 6.88 % | 104.52 % | 112.70 % | 113.51 % |
| YTD | -47.30 % | -41.23 % | -26.99 % | -22.58 % | -7.56 % | 41.32 % | -4.75 % | 174.46 % | 5.47 % | 140.00 % |
| 1Y | -17.64 % | -65.64 % | -39.29 % | -14.16 % | 47.67 % | 3.23 % | -17.32 % | 130.55 % | 67.96 % | 1.80 % |
| 3Y | -55.23 % | -85.54 % | -69.68 % | -21.81 % | -85.21 % | 351.63 % | 27.37 % | -52.83 % | -87.02 % | -73.71 % |
| 5Y | -55.23 % | -89.66 % | -94.35 % | -64.59 % | -66.79 % | -43.61 % | -86.21 % | 129.71 % | -41.39 % | -83.45 % |
| 10Y | -55.23 % | -89.66 % | -95.10 % | -69.63 % | -90.43 % | -90.95 % | -98.57 % | 3 030.86 % | -32.52 % | -83.45 % |
| From the beginning | -55.23 % | -89.66 % | -95.10 % | -69.63 % | -90.43 % | -90.95 % | -98.57 % | 3 030.86 % | -32.52 % | -83.45 % |